admin

Empowering Corporate Innovation in HealthTech – How corporates benefit from Startup innovation

How corporates benefit from Startup innovation In the rapidly evolving landscape of healthcare and medical technology, startups’ role as innovation catalysts is undeniable. MEDKAP, a Swiss non-profit investor association, stands at the forefront of this transformation by bridging the gap between innovative startups and established corporations. This article explores the strategic advantages of corporate members

Empowering Corporate Innovation in HealthTech – How corporates benefit from Startup innovation Read More »

Adopting Healthcare Innovation in Hospitals – What Startups should consider

Which Healthcare Innovation is Needed in Hospitals? Hospitals today are facing a clear call for innovation, especially in how their processes work and evolve. Two broad categories of process innovation stand out as vital: one aimed at enhancing medical outcomes and the other focused on improving patient and staff experience, as well as operational efficiency.

Adopting Healthcare Innovation in Hospitals – What Startups should consider Read More »

Investing in the Future of Healthcare: The Booming Diagnostics Market

Imagine a world where a simple blood test could detect cancer years before symptoms appear, or where a wearable device could predict a heart attack days in advance. This isn’t science fiction—it’s the rapidly evolving field of medical diagnostics. MEDKAP, the angel investor club focused on HealthTech, is sharing with you why investing in diagnostics

Investing in the Future of Healthcare: The Booming Diagnostics Market Read More »

Angel Investing 2.0: MEDKAP’s guiding principles

MEDKAP’s guiding principles for HealthTech angel investing, supporting startups and investors with efficient processes and industry expertise. Startup funding by individuals has always been and still is a relevant funding source for early-stage startups. MEDKAP is a young angel club to invest in HealthTech startups. This blog article sheds light on how we’ve set up MEDKAP and

Angel Investing 2.0: MEDKAP’s guiding principles Read More »

Digital Health and DiGA as an Investment Case – Investors perspective

The German DiGA Market from the Investor’s Perspective Part 3: Is DiGA an interesting investment case? Investing in a DiGA manufacturer is not a straightforward case. The founder, retrospectively management team is fundamental for success, they need to have a very clear and focused Go to Market strategy in place and ideally concentrate on commercially

Digital Health and DiGA as an Investment Case – Investors perspective Read More »

Digital Health and DiGA as an Investment Case – Commercial Challenges

The German DiGA Market from the Investor’s Perspective Part 2: Commercial Challenges of the DiGA Business Model As part 1 of the blog series illustrates, total Rx/Revenue volume for individual DiGAs did not go through the roof in contradiction to early predictions of e.g. consultancies or investors. Even the market leader zanadio “only” achieved 28k Rx

Digital Health and DiGA as an Investment Case – Commercial Challenges Read More »

Digital Health and DiGA as an Investment Case – DiGA Market

The German DiGA Market from the Investor’s Perspective Part 1: Introduction and Status Quo of the DiGA Market in Germany September 2020 marked a turning point for the commercialization of Digital Health in Germany…and worldwide. The first fully reimbursed Digital Health Applications (DiGA: Digitale Gesundheitsanwendungen) were launched in Germany based on the Digital Healthcare Act

Digital Health and DiGA as an Investment Case – DiGA Market Read More »

TechBio as a New Investment Case – Opportunities for Big Exits

TechBio: The Convergence of Technology and Biology Reshaping Healthcare TechBio, short for Technology Biology, represents a groundbreaking convergence of cutting-edge technologies, computational methods, and data-driven approaches applied to biological research and drug development. This emerging field is revolutionizing the healthcare industry by accelerating innovation, reducing costs, and improving patient outcomes [1][4]. At its core, TechBio

TechBio as a New Investment Case – Opportunities for Big Exits Read More »

Scroll to Top